Skip to main content
Caplight Logo









Purinomia Biotech

Purinomia Biotech

Private
Woburn, MassachusettsHealthcare & Life Scienceshttps://purinomia.com

Last Round

Debt

Jun 7, 2024

Total Funding Raised

$9.01M

Company Overview

Purinomia Biotech operates in Healthcare & Life Sciences and is based in Woburn, Massachusetts. Its latest recorded funding round was a Debt round in June 2024.

Purinomia Biotech is a biotechnology company that develops therapeutics for cancer and inflammatory diseases by targeting purinergic signaling pathways.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Purinomia Biotech Comparables

Compare Purinomia Biotech with similar companies based on industry and business-model similarity.

Purinomia Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Trishula Therapeutics
91%
OREGA Biotech
84%
iTeos Therapeutics
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Purinomia Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtJun 7, 2024
DebtOct 25, 2023
DebtApr 7, 2023
SeedDec 23, 2022
VC RoundDec 21, 2021
Seed
Feb 12, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 3, 2025

    Monthly visitors increased 43% MoM.

  • Nov 12, 2024

    Monthly visitors grew 135% MoM, reaching 365.

Book a demo to see all signals

For institutional investors. Book with your work email.

Purinomia Biotech Filings

Explore SEC and related filing metadata, where available.

Purinomia Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Purinomia Biotech's valuation, stock price, and market status.

Is Purinomia Biotech a public or private company?

Purinomia Biotech is a private company.

What is the current stock price of Purinomia Biotech?

Purinomia Biotech is a private company, so its shares have no public market price. Caplight tracks Purinomia Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Purinomia Biotech worth (valuation)?

Valuation information for Purinomia Biotech is not publicly available.

Can I buy Purinomia Biotech stock?

Purinomia Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Purinomia Biotech's last funding round?

Purinomia Biotech's most recent funding round was Debt on June 7, 2024.

Who are the main investors in Purinomia Biotech?

Investor information for Purinomia Biotech is not publicly disclosed.

Will Purinomia Biotech IPO soon?

No public IPO plans have been announced for Purinomia Biotech.

How can I track Purinomia Biotech secondary market activity?

Caplight tracks bids, offers, and trades in Purinomia Biotech's shares on secondary markets.

Firmographic Details

HeadquartersWoburn, Massachusetts
Employee Range2
Year Founded2017
Last FundingJun 7, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?